Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Immune Disease Start-Up Raises $28M in Early Funds

A new company founded to develop treatments for diseases caused by problems with the immune system is raising $28.4 million in its first round of financing. . . . → Read More: Immune Disease Start-Up Raises $28M in Early Funds

Coalition to Make 10,000 Open-Access Synthetic Genes

A company with a process for creating synthetic DNA and a foundation promoting open access to biotechnology agreed to produce 10,000 synthetic genes made available at no cost to researchers. . . . → Read More: Coalition to Make 10,000 Open-Access Synthetic Genes

$300M Fund to Back European Life Science Companies

A new investment fund plans to invest $300 million in European life science and biotechnology companies in the later stages of their product development. . . . → Read More: $300M Fund to Back European Life Science Companies

Report: Growing Tech Industry Investment in Health

The information technology industry is a growing presence in health care, both financially and qualitatively, according to a new report. . . . → Read More: Report: Growing Tech Industry Investment in Health

Fund Created for Point-of-Care Diagnostics, Treatment

A venture capital company is beginning a $60 million investment fund that plans to finance start-up enterprises providing point-of-care diagnostics and medical treatments. . . . → Read More: Fund Created for Point-of-Care Diagnostics, Treatment

Liquid Biopsy Company Gains $360M for Cancer Sequencing

A company using blood tests to diagnose cancer is receiving a $360 million investment for its campaign to sequence DNA from 1 million people at high risk of cancer. . . . → Read More: Liquid Biopsy Company Gains $360M for Cancer Sequencing

$2 Billion Biotech Licensing Deal Cancelled

A licensing deal with a potential value of more than $2 billion between two biotechnology companies for a new breast cancer drug was cancelled on Friday. . . . → Read More: $2 Billion Biotech Licensing Deal Cancelled

Gene Therapy Start-Up Raises $41M in Early Funds

A 1 year-old enterprise developing gene therapies to treat rare inherited metabolic disorders is raising €37.5 million ($US 40.8 million) in its first venture funding round. . . . → Read More: Gene Therapy Start-Up Raises $41M in Early Funds

Organ Transplant Start-Up Gains $38M in Early Funds

A one year-old company applying genome editing to make animal organs fit for human transplantation is raising $38 million its first venture funding round. . . . → Read More: Organ Transplant Start-Up Gains $38M in Early Funds

Cancer Blood Test Company Raises $65M in Early Funds

Freenome, a company applying machine learning to analysis of liquid biopsies, is raising $65 million in its first round of venture financing. . . . → Read More: Cancer Blood Test Company Raises $65M in Early Funds